“…The initial step was based on biophysical properties of BM stromal cells, i.e., density, nonadherence, and lectin-binding. (22,30,31) The second stage was, by analogy with the purification of hematopoietic progenitors from BM, a positive selection procedure based on magnetic activated cell sorting (MACS) and utilizing a murine monoclonal antibody (MAb), STRO-1, (7) which recognizes all the clonogenic stromal precursors in human marrow, including all assayable osteoprogenitors. (7,32,33) With the aim of generating clonogenic STRO-1 + cells, the immunoselected cell population was immortalized with an origindefective mutant of the SV-40 large tumor antigen (T-Ag) (34) and cloned.…”